Skip to content

ophthafutur deca

by Pharmpur GmbH Germany EUDAMED

Ref 500502

EMDN Q02030205

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-04260260050153 Basic UDI-DIDate8 Oct 2021RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
ophthafutur deca (5ml syringe)
Model / Reference
500502
Primary DI / UDI-DI
04260260050153
Basic UDI-DI
B-04260260050153
EMDN Code
Q02030205 Ophthalmic surgery, perfluorocarbons pure and combined with other substances
Device Class
Class IIa
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000008337

Other devices from Pharmpur GmbH

See all devices from Pharmpur GmbH →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
Other properties (10)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 7ec54f4e-9e2d-4bae-80f6-bde7f4f46b4e 61 fields · synced 22 Oct 2026